Alnylam Pharmaceuticals (NASDAQ:ALNY) Target Raised by Morgan Stanley to $242.00

StockMarketDaily.co reports: Alnylam Pharmaceuticals stock has undergone multiple analysts rating changes in the recent past.  Alnylam Pharmaceuticals stock Target Raised by   Morgan Stanley on 10/12/2021. In a note to investors, the firm issued a new target price of $242.00. The analysts previously had $234.00 target price.

View More Alnylam Pharmaceuticals (NASDAQ:ALNY) Target Raised by Morgan Stanley to $242.00